Associate Director, HEOR & RWE

Servier
Servier logo
Location
Boston
Job Type
Full-time
Posted
October 22, 2026
Salary Range
$184k - $218k USD

Job Description

About Servier

Servier in the U.S. is a Boston-based, commercial-stage biopharmaceutical company launched by Servier Group in 2018. As a privately held organization, Servier is uniquely positioned to advance cutting-edge science, tackle underserved therapeutic areas and make patients the focus of every strategic decision.

The Associate Director, HEOR/RWE (Emi-Le and Solid Tumor Pipeline), is a key member of the HEOR and Scientific Communication team within the US Medical Affairs organization. This individual is responsible for the strategic development and execution of early evidence generation initiatives for Servier’s oncology programs, including Emi-Le (e.g., ACC), DAY301 and additional pipelines.

The primary focus of this role is to identify and address unmet medical needs, access barriers, and value gaps prior to launch. The Associate Director  will spearhead the development of Patient-Reported Outcome (PRO) strategies to capture the patient voice and design innovative RWE solutions, such as external control arms to contextualize clinical data from single-arm trials. Furthermore, this individual is responsible for driving launch evidence readiness, ensuring that robust health economic models, AMCP dossiers, and real-world datasets are developed in time to support successful launch. By partnering closely with Clinical Development, Translational Science, and US Medical/Access teams, this individual ensures that the early evidence base robustly supports future value demonstration and reimbursement pathways for these high-priority pipeline assets.

Primary Responsibilities

Key Responsibilities: Associate Director

  • Strategic Leadership & Planning:
  • Lead the development of comprehensive evidence strategy (e.g., economic, comparative effectiveness) and operational plans for pipeline assets, with a focus on establishing early value propositions for Emi-Le (ACC).
  • Identify and address unmet medical needs and access barriers in collaboration with cross functional teams to enable development of robust health economic and value narratives.
  • Collaborate with clinical development teams to design and incorporate PRO measures within early-phase clinical trials, serving as a Subject Matter Expert (SME) for engagements with regulatory and payer bodies.
  • Provide scientific support to facilitate early market access planning and preparatory payer engagements for the pipeline portfolio.
  • Maintain an up-to-date awareness of the industry's regulatory, payer, and policy landscape, particularly regarding the use of RWE and PROs in oncology and assess its potential impact on evidence generation.
  • Mentor junior team members and contribute to a culture of learning, integrity, and innovation within the Value, Evidence, and Communication function.
  • Evidence Generation and Impact Measurement:
  • Oversee the end-to-end delivery of RWE studies (e.g., database analysis, chart reviews, prospective registries) to characterize unmet needs and disease burden in niche solid tumor indications.
  • Design and execute innovative RWE solutions, such as external control arms, to provide essential comparative context for clinical data derived from single-arm trials.
  • Deliver "launch-ready" U.S. economic models and AMCP dossiers to optimize patient access and reimbursement ahead of commercial market entry.
  • Ensure all research initiatives strictly adhere to internal study governance processes, ensuring high ethical and scientific standards, including obtaining necessary internal approvals and cross-functional alignment.
  • Work with external vendors and internal teams to design and execute pipeline oncology evidence projects, ensuring timely and quality delivery while managing budgets and CRO performance.
  • Ensure timely measurement and communication of the external and internal impact of generated evidence to demonstrate value to the organization.
  • Translate research outputs into practical tools (e.g., value decks, proactive/reactive field materials) in collaboration with the scientific communications team, equipping field medical and access teams for future launches.
  • Alliance Management & Global Collaboration:

About Servier

Servier in the U.S. is a Boston-based, commercial-stage biopharmaceutical company launched by Servier Group in 2018. As a privately held organization, Servier is uniquely positioned to advance cutting-edge science, tackle underserved therapeutic areas and make patients the focus of every strategic decision.

The Associate Director, HEOR/RWE (Emi-Le and Solid Tumor Pipeline), is a key member of the HEOR and Scientific Communication team within the US Medical Affairs organization. This individual is responsible for the strategic development and execution of early evidence generation initiatives for Servier’s oncology programs, including Emi-Le (e.g., ACC), DAY301 and additional pipelines.

The primary focus of this role is to identify and address unmet medical needs, access barriers, and value gaps prior to launch. The Associate Director  will spearhead the development of Patient-Reported Outcome (PRO) strategies to capture the patient voice and design innovative RWE solutions, such as external control arms to contextualize clinical data from single-arm trials. Furthermore, this individual is responsible for driving launch evidence readiness, ensuring that robust health economic models, AMCP dossiers, and real-world datasets are developed in time to support successful launch. By partnering closely with Clinical Development, Translational Science, and US Medical/Access teams, this individual ensures that the early evidence base robustly supports future value demonstration and reimbursement pathways for these high-priority pipeline assets.

Primary Responsibilities

Key Responsibilities: Associate Director

  • Strategic Leadership & Planning:
  • Lead the development of comprehensive evidence strategy (e.g., economic, comparative effectiveness) and operational plans for pipeline assets, with a focus on establishing early value propositions for Emi-Le (ACC).
  • Identify and address unmet medical needs and access barriers in collaboration with cross functional teams to enable development of robust health economic and value narratives.
  • Collaborate with clinical development teams to design and incorporate PRO measures within early-phase clinical trials, serving as a Subject Matter Expert (SME) for engagements with regulatory and payer bodies.
  • Provide scientific support to facilitate early market access planning and preparatory payer engagements for the pipeline portfolio.
  • Maintain an up-to-date awareness of the industry's regulatory, payer, and policy landscape, particularly regarding the use of RWE and PROs in oncology and assess its potential impact on evidence generation.
  • Mentor junior team members and contribute to a culture of learning, integrity, and innovation within the Value, Evidence, and Communication function.
  • Evidence Generation and Impact Measurement:
  • Oversee the end-to-end delivery of RWE studies (e.g., database analysis, chart reviews, prospective registries) to characterize unmet needs and disease burden in niche solid tumor indications.
  • Design and execute innovative RWE solutions, such as external control arms, to provide essential comparative context for clinical data derived from single-arm trials.
  • Deliver "launch-ready" U.S. economic models and AMCP dossiers to optimize patient access and reimbursement ahead of commercial market entry.
  • Ensure all research initiatives strictly adhere to internal study governance processes, ensuring high ethical and scientific standards, including obtaining necessary internal approvals and cross-functional alignment.
  • Work with external vendors and internal teams to design and execute pipeline oncology evidence projects, ensuring timely and quality delivery while managing budgets and CRO performance.
  • Ensure timely measurement and communication of the external and internal impact of generated evidence to demonstrate value to the organization.
  • Translate research outputs into practical tools (e.g., value decks, proactive/reactive field materials) in collaboration with the scientific communications team, equipping field medical and access teams for future launches.
  • Alliance Management & Global Collaboration:
  • Coordinate with Servier Global counterparts to ensure US pipeline evidence generation strategies (e.g., PRO selection, RWE design) complement and support global value narratives.
  • Manage the collaborative review of evidence generation plans within joint alliance frameworks to ensure consistency in the global value story for pipeline assets.
  • Communication & Stakeholder Engagement:
  • Lead communication with Medical Affairs and other functional leadership on planned and ongoing pipeline research initiatives, key findings, and their strategic impact.
  • Drive pull-through and communication of evidence strategy to internal and external stakeholders, including cross-functional asset and governance teams, healthcare decision-makers, and clinical practitioners.
  • In collaboration with the Patient Advocacy team, champion the "Patient Voice" by effectively communicating the results of PRO strategies and unmet need studies to internal and external experts to shape the perceived value of the pipeline.

Education and Required Skills: Associate Director

  • Advanced degree (PhD, PharmD, MS) in Health Outcomes, Pharmacoeconomics, Epidemiology, or a related field, with relevant experience in oncology.
  • 6+ years of experience in the pharmaceutical or healthcare industry, specifically within a Value, Evidence, and Communication function (or equivalent HEOR, RWE, Medical Evidence Generation), with proven experience in early-stage pipeline evidence strategy development and execution.
  • Deep expertise in innovative RWE methodologies required for pipeline assets, including the design of external/synthetic control arms to contextualize single-arm clinical trials and the characterization of unmet medical needs in rare oncology indications.
  • Strong knowledge of the U.S. regulatory framework and payer landscape, with specific experience designing and implementing evidence strategies (e.g., natural history studies, PRO selection) that meet both payer and regulatory requirements for novel therapies.
  • Advanced technical expertise in outcomes research, economic modelling, and PRO research, coupled with excellent communication skills to effectively convey complex scientific data to varied audiences.
  • Proven track record in driving "launch evidence readiness," including the development of AMCP dossiers, value stories, and economic models tailored for initial market entry.
  • Strong project management capabilities and the ability to work effectively in a matrix organization, ensuring adherence to internal study governance and scientific standards.
  • Effective in communicating research findings and able to translate these into actionable insights and compelling value narratives for diverse internal and external stakeholders.
  • Proven ability to manage complex projects, alliance partnerships, and cross-functional initiatives with strategic agility and attention to detail.
  • Collaborative leadership style with a track record of working across teams, functions, and geographies to drive functional excellence.
  • High emotional intelligence, with the ability to lead through influence, resolve challenges, and build consensus in a matrixed organization, particularly when managing the evolving data sets of pipeline assets.

Travel and Location

  • Boston Based, hybrid role reporting to the Seaport office 2-3x per week
  • 15-20% Travel

Candidate Profile

Servier’s Commitment

Servier is committed to modeling diversity, equity, and inclusion within the industry. We are dedicated to fostering an environment that maintains equitable treatment for all and we welcome applicants who are passionate, committed, and innovative individuals. We encourage candidates to apply to our open roles as we are always willing to consider experiences and skills beyond what is listed in the job description.

All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, or status as a protected veteran.

Salary Range

The salary range for this role is $184,000 - $218,000. An employee’s pay position within the salary range will be based on several factors including, but not limited to, relevant education, qualifications, certifications, experience, skills, geographic location, performance, and business or organizational needs. We may ultimately pay more or less than the posted range, and the range may be modified in the future. Employees in this position are also eligible for Short-Term and Long-Term incentive programs. Servier also offers a competitive and comprehensive benefits package that includes benefits such as medical, dental, vision, flexible time off (Servier provides unlimited sick time and flex time, and does not accrue time off), 401(k), life and disability insurance, recognition programs among other great benefits (all benefits are subject to eligibility requirements).  For more information on our benefits, please visit this link.

Frequently Asked Questions

Where is this role located, and what is the work-mode policy?
The role is based in Boston as a hybrid position requiring on-site work at the Seaport office 2 to 3 days per week, along with 15-20% travel.
What qualifications and experience are required for this position?
Candidates need an advanced degree (PhD, PharmD, MS) in Health Outcomes, Pharmacoeconomics, Epidemiology, or a related field, plus 6+ years of pharmaceutical or healthcare industry experience in HEOR, RWE, or Medical Evidence Generation, with specific expertise in early-stage oncology pipeline strategy and innovative RWE methodologies.
What are the primary responsibilities of the Associate Director, HEOR & RWE?
Responsibilities include leading evidence strategies for pipeline assets, designing RWE solutions like external control arms, incorporating PRO measures into early clinical trials, creating launch-ready economic models and AMCP dossiers, managing vendor projects and budgets, and collaborating across US and global teams.
What is the salary range for this role?
The base salary range is $184,000 to $218,000, depending on education, experience, skills, location, and organizational needs. Employees are also eligible for short-term and long-term incentive programs.
What benefits does Servier offer?
Servier offers a comprehensive benefits package including medical, dental, and vision insurance, flexible time off (unlimited sick and flex time), a 401(k) plan, life and disability insurance, and recognition programs.
What team will I be joining and are there any supervisory duties?
The role is part of the HEOR and Scientific Communication team within the US Medical Affairs organization. While direct reporting lines are not specified, duties include mentoring junior team members within the function.

Ready to Apply?

Apply for this Position

You'll be redirected to the company's application page

Share this job:
WhatsApp LinkedIn X Email

Job Information

Source: manual
AI Relevance: 85/100 (Highly relevant)
Remote Type: onsite
Skills & Tags:
servier oncology clinical

Get Similar Jobs by Email

Weekly digest of Servier and similar companies. Free.

Related Jobs

Apply for this Position

Get weekly job alerts